A 10-year-old boy with perinatally acquired HIV returns to your clinic for routine follow-up. He has maintained suppressed HIV RNA levels for years on a regimen of nevirapine, zidovudine, and lamivudine. He has no history of HIV drug resistance. He is able to swallow pills, but he is having increasing side effects with this regimen and does not like the twice-daily dosing and the number of pills. You are considering switching to a new regimen that includes an integrase strand transfer inhibitor (INSTI). He weighs 32 kg and has a sexual maturity rating (SMR) of 2.
Based on recommendations from the Pediatric ART Guidelines, which one of the following oral medications would be considered a preferred INSTI-based regimen for this 10-year-old boy who can swallow pills?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
February 2nd, 2025
February 2nd, 2025
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant